调节性T细胞在人乳头瘤病毒16整合状态的宫颈癌组织中的表达及意义被引量：3

The expression of Treg in HPV16 integrated cervical cancer

导出

摘要目的探讨调节性T细胞(Treg)活化与人乳头瘤病毒(HPV)16存在状态的关系及其与HPV16整合状态的宫颈鳞癌患者临床病理资料之间的相关性。方法 2012年1-10月在中国医科大学附属盛京医院妇产科,采用多重实时PCR技术对HPV16阳性的17例正常宫颈组织、65例宫颈上皮内瘤变(CIN)、60例宫颈鳞癌(CC)的宫颈脱落细胞标本检测E2和E6基因,通过E2/E6比值法评估HPV16 DNA的体内存在状态。采用免疫组化方法检测相应宫颈组织中叉头状/翅膀状螺旋转录因子(Foxp3)的表达。结果 Foxp3阳性积分光密度值在HPV16游离状态、整合状态宫颈组织中,均与宫颈病变严重程度呈正比,在CC与CINⅢ组比较差异有统计学意义(P<0.05)。在同一病变中,HPV16整合型组Foxp3阳性表达均高于游离型组,在CC组比较差异有统计学意义(t=-2.685,P<0.05)。Foxp3阳性在HPV16整合状态宫颈鳞癌中的表达与FIGO分期、组织学分级及淋巴结转移相关(P<0.05),而与年龄无关(P>0.05)。结论 Treg与HPV存在状态密切相关,Treg在HPV持续感染所致宫颈癌的发生及发展中可能起着重要作用。 Objective To analyze the relationship between Treg activation and the existence state of HPV, as well as the relationship between Treg activation and clinicopathological features of integrated cervical cancer. Methods Between January 2012 and October 2012, in Shengjing Hospital of China Medical University, cervical liquid-based cytological （ LBC ） samples from patients with normal cervical uteri （ n = 17 ）, CIN tissues （ n = 65 ）, cervical squamous cancer（ n = 60） were detected E2 and E6 genes of HPV type 16 using multiple polymerase chain reaction （PCR）. E2/E6 ratio was used to evaluate the physical status of HPV-16 DNA in host cell genome. The SP immunohistochemical method was used to detect the expressions of Foxp3 in all cases. Results Foxp3＋ integrated optical density value in the HPV16 free, integrated cervical tissue were increased with the severity of cervical lesions increased, CC and CINIII group was more statistically significant （ P 〈 0.05 ）. In the same lesions, integrated group of Foxp3＋ expression higher than free type group, in the CC group was more statistically significant than CIN （ t = - 2. 685, P 〈 0. 05 ）. The expression of Foxp3＋ in integrated cervical squamous carcinoma was correlated with FIGO stages, histological grade, lymph node metastasis （ P 〈 0. 05 ） and is independent of age （ P 〉 0.05 ）. Conclusion Treg is closely related to HPV persistence,Treg may play an important role in the occurrence and development of cervical cancer caused by HPV persistent infection.

作者丁爱萍张志新张瑶魏恒张淑兰

机构地区中国医科大学附属盛京医院妇产科常州市妇幼保健院妇产科中国人民解放军第

出处《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2014年第5期374-378,共5页 Chinese Journal of Practical Gynecology and Obstetrics

基金国家自然科学基金资助项目(81372776) 辽宁省医学高峰建设工程项目(2010696) 辽宁省科学技术计划项目(2011225009) 盛京自由研究者计划(201302) 高等学校博士学科点专项科研基金(20122104110014)

关键词宫颈鳞癌调节性T细胞 HPV16 病毒整合 cervical squamous carcinoma Treg HPV-16 subtype virus integration

分类号 R711.74 [医药卫生—妇产科学]

引文网络
相关文献

参考文献9

1Rodriguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections [J]. J Natl Cancer Inst, 2008,100 (7) : 513- 517.
2Watanabe M,Kono K,Kawaguchi Y,et al. Interleukin-21 can efficiently restore impaired antibody-dependent cell-mediated cytotoxicity in patients with oesophageal squamous cell carcinoma [J]. Br J Cancer,2010,102(3) :520-529.
3陈庆云,卞美璐,陈志华,刘军.宫颈癌癌前病变中人乳头状瘤病毒16整合状态的检测[J].中华医学杂志,2005,85(6):400-404. 被引量：13
4Boulet GA, Benoy IH, Depuydt CE, et al. Human Papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia> or = 2 in a liquid-based cytology setting? [J]. Cancer Epidemiol Biomarkers Prey ,2009 , 18 ( 11 ) : 2992-2999.
5De Freitas AC, Gurgel AP, Chagas BS, et al. Susceptibility to cervical cancer: an overview [J]. Gynecol Oncol, 2012,126 (2) :304-311.
6Hafner N,Driesch C,Gajda M,et al. Integration of the HPV16 genome does not invariablyresult in high levels of viral oncogene transcripts [J] . Oncogene ,2008,27 (11) : 1610-1617.
7Saunier M ,Monnier-Benoit S,Mauny F ,et al. Analysis of human papillomavirus type 16 ( HPV16) DNA laod and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma [J]. J Clin Microbiol, 2008 , 46 (11 ) :3678-3685.
8Visser J, Nijman HW, Hoogenboom BN, et al. Frequencies and role of regulatory T cells in patients witb (pre) malignant cervical neoplasia[J]. Clin Exp Immunol,2007 ,150(2) :199-209.
9Sasagawa T, Takagi H, Makinoda S. Immume responses against buman papillomavirus (HPV) infection and evasion of host defense in cervical cancer[J]. J Infect Chemother ,2012,18 (6) : 807-815.

二级参考文献22

1Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev, 2003,16: 1-17.
2Huang S, Afonina I, Miller BA, et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer, 1997, 70: 408-411.
3Zou C, Vlastos AT, Yang L, et al. Effects of difluoromethylornithine on growth inhibition and apoptosis in human cervical epithelial and cancerous cell lines. Gynecol Oncol, 2002, 85: 266-273.
4de Roda Husman AM, Walboomers JM, van den Brule AJ, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol, 1995, 76: 1057-1062.
5Hirai Y,Kawamata Y,Takeshima N,et al.Conventional and array-based comparative genomic hybridization analyses of novel cell lines harboring HPV18 from glassy cellcarcinoma of the uterine cervix.Int J Oncol,2004,24:977-986.
6Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5+/6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol, 1997, 35: 791-795.
7Yoshinouchi M, Hongo A, Nakamura K, et al. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers. J Clin Microbiol, 1999, 37: 3514-3517.
8Lukaszuk K, Liss J, Wozniak I, et al. Human Papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR. J Clin Microbiol, 2003, 41: 608-612.
9Badaracco G, Venuti A, Sedati A, et al. HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol, 2002, 67: 574-582.
10Vassilakos P, Petignat P, Boulvain M, et al. Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing. Br J Cancer, 2002, 86: 382-388.